Purdue Pharma has submitted a revised Chapter 11 bankruptcy plan proposing more than $7.4 billion in cash payments to creditors, including U.S. states and others, to compensate victims of the opioid crisis, Bloomberg reported March 18.
The plan includes the dissolution of Purdue and the creation of a new public benefit company, which will operate independently of the company’s current owners, the Sackler family.
Under the proposal, the Sacklers would contribute up to $6.5 billion over 15 years, with an initial $1.5 billion payment when the reorganization takes effect.
The bankruptcy case has been the center of legal disputes between the Sackler family and a bipartisan group of state attorneys general who alleged the opioid epidemic, which has killed hundreds of thousands of Americans, was exacerbated by the marketing and sale of Purdue Pharma’s OxyContin painkiller. As a result, the company filed for bankruptcy protection in 2019.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.